Evidence map›Paper›PMID 38175899›Full record

ArticleScience (New York, N.Y.)2024

Restoring tolerance with antigen delivery.

Bana Jabri, Valérie Abadie

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Can we cure vasculitis?Current opinion in immunology · 2025
    Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bana JabriSection of Gastroenterology, Hepatology and Nutrition, University of Chicago Department of Medicine, Chicago, IL, USA.
Valérie AbadieSection of Gastroenterology, Hepatology and Nutrition, University of Chicago Department of Medicine, Chicago, IL, USA.

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI CHANG, EUGENE B · 1990 to 2025
$29.8M
Role of Transglutaminase 2 in Celiac SprueR01DK063158 · NIDDK · STANFORD UNIVERSITY · PI CHAITAN KHOSLA · 2003 to 2026
$11.2M
Innate and adaptive immunity in celiac diseaseR01DK067180 · NIDDK · UNIVERSITY OF CHICAGO · PI JABRI, BANA · 2005 to 2024
$8.5M
B cell-T cell crosstalk in celiac diseaseR01DK128352 · NIDDK · UNIVERSITY OF CHICAGO · PI ABADIE, VALERIE · 2021 to 2025
$2.1M
Digestive Diseases Research Core Center P30 DK42086 AND R01 DK063158National Institutes of Health (NIH) R01 DK067180 TO B.J., R01 DK128352NIDDK NIH HHS P30 DK042086NIDDK NIH HHS R01 DK063158NIDDK NIH HHS R01 DK067180NIDDK NIH HHS R01 DK128352
6 · The paper itself

Abstract

Strategies that modulate antigen delivery are being tested to reverse autoimmunity.

Indexed as

AutoantigensAutoimmune DiseasesDesensitization, ImmunologicSelf ToleranceAnimalsAntigen PresentationAntigen-Presenting CellsAutoimmunityHumansMiceAutoantigens

Identifiers

PMID38175899
PMCPMC12268879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.